A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model.
about
Guidelines for the use and interpretation of assays for monitoring autophagyMutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodiesMutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neuronsAutophagy in ageing and ageing-associated diseasesPhysicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)The neurology of mTORLongitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative diseaseProtein homeostasis as a therapeutic target for diseases of protein conformationFluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyAutophagy in neurodegenerative diseases: from mechanism to therapeutic approachATP13A2 regulates mitochondrial bioenergetics through macroautophagyPotential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseasesAutophagy activation is involved in 3,4-methylenedioxymethamphetamine ('ecstasy')--induced neurotoxicity in cultured cortical neuronsNeuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1High-throughput screening in primary neuronsAutophagy induction enhances TDP43 turnover and survival in neuronal ALS models.Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.Targeting SQSTM1/p62 induces cargo loading failure and converts autophagy to apoptosis via NBK/Bik.Autophagy-regulating small molecules and their therapeutic applications.Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin.Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiencyTargets for future clinical trials in Huntington's disease: what's in the pipeline?The biology of proteostasis in aging and disease.A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.Autophagy-mediated turnover of dynamin-related protein 1.Autophagy failure in Alzheimer's disease--locating the primary defect.Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis.A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseasesCombination of Rad001 (everolimus) and propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cellsIdentification of natural products with neuronal and metabolic benefits through autophagy induction.Lysosomal adaptation: How cells respond to lysosomotropic compounds.Tor1 regulates protein solubility in Saccharomyces cerevisiae.Motor neuron-specific disruption of proteasomes, but not autophagy, replicates amyotrophic lateral sclerosisMethylene blue induces macroautophagy through 5' adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivationA novel sulindac derivative inhibits lung adenocarcinoma cell growth through suppression of Akt/mTOR signaling and induction of autophagySonic hedgehog promotes autophagy in hippocampal neurons.Levetiracetam mitigates doxorubicin-induced DNA and synaptic damage in neuronsClinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.Compartment-Specific Regulation of Autophagy in Primary Neurons.Disorders of protein misfolding: alpha-1-antitrypsin deficiency as prototype.
P2860
Q21996341-A5AEBD02-8980-4C1B-8414-BBAA373F6792Q24318474-4A9FE1C7-9601-4577-85AE-133CBC40FBF5Q24628425-FCB0F860-38D3-4255-BA5B-D9116F996DFAQ24629560-005C2076-0E1F-4461-8E17-9022B4E47508Q26823798-E443ACEF-839C-47D0-A4F9-CA36100A75CDQ26824286-68FF405C-B25B-45C0-AF87-E619E4BDB7EBQ26865220-91131C9F-A24F-47B3-B721-DBACE915B552Q27003283-FD03C317-6397-439A-9E0A-830FA1779AADQ27324830-0D4BB2F3-DEC9-437F-9ED7-21F2F2EC8FD8Q28084605-8D2AE187-6104-4BD4-B377-81DA1541F30CQ28116275-956A1748-B84A-45E4-8381-1D748267A8A8Q28391383-CC9265B0-E373-4FC6-A7AA-CD4C189E573CQ28542949-8EF77B7B-14F8-4014-B75B-3B2AB9D9F552Q28575722-B2F525EC-79AD-4AB9-8BED-D4A957AB58D6Q28709230-E5709D55-2DAF-447D-B7EE-CAEC929460FCQ33930825-6AE9C776-2ECB-4785-9C12-02B069518D11Q34014433-5F0F619D-5E48-479E-9A73-8E0E4CE10C36Q34056627-FDD0DEC1-DF1C-46A6-93F6-5A91D05F37EDQ34147157-31366CA2-123E-436F-A26E-A7F2BE6DEDACQ34221351-1D107B46-A33E-4843-ACCE-B8A293E2107EQ34241393-4AC02F60-F4A5-42FF-B164-C40092FFB240Q34435001-26D198B4-586F-4420-B717-D1695680068BQ34467650-1F06D1BA-48E0-4546-8D3D-19C5E8772FC2Q34582206-2438FF6B-31C1-4D9E-852C-94707AF71663Q34927824-C54A8469-60CE-4F76-AB71-69C7FEDD7505Q34987827-FB678EDE-9498-4FA8-BA56-5969C0DA774AQ35501802-903FAF9D-CF08-4774-8703-A41EA4CDDBF0Q35976721-4A74F247-C92C-4F40-A252-4AFCD20F9B91Q36028196-458837F1-FA64-47D8-9164-B42661AE03A6Q36176980-5E41C823-7EE0-47BA-98F7-DEBA23C2329FQ36310581-72CBA461-E851-4CB4-8DC0-033729AA0213Q36465061-B95CE92E-D67E-4BC7-AAD1-BAAC9414778BQ36466787-C7FD435E-122F-46FE-8B38-3DD25A72127AQ36812658-6E4B69B6-1564-4C31-8D86-D076A0BE34E8Q36836915-6BE45CB1-9467-4019-B4D3-7699A2B0A761Q36844785-65881B3C-0719-4A5D-87BE-4203182E9F3AQ36890652-FB8E3E8D-3958-4C67-8152-6B0FE9C653C8Q36904682-092EDDBF-BFD8-4EA8-9E67-CB4E24A92D08Q36952634-9B22D041-8C6A-4EE7-9F6F-6BC080324E28Q37049924-70780C5D-E246-4790-A4C5-CBCF9F0A56C0
P2860
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A small-molecule scaffold indu ...... in a Huntington disease model.
@ast
A small-molecule scaffold indu ...... in a Huntington disease model.
@en
A small-molecule scaffold indu ...... in a Huntington disease model.
@nl
type
label
A small-molecule scaffold indu ...... in a Huntington disease model.
@ast
A small-molecule scaffold indu ...... in a Huntington disease model.
@en
A small-molecule scaffold indu ...... in a Huntington disease model.
@nl
prefLabel
A small-molecule scaffold indu ...... in a Huntington disease model.
@ast
A small-molecule scaffold indu ...... in a Huntington disease model.
@en
A small-molecule scaffold indu ...... in a Huntington disease model.
@nl
P2093
P2860
P356
P1476
A small-molecule scaffold indu ...... in a Huntington disease model
@en
P2093
Andrey S Tsvetkov
Jinny S Wong
Michael A Pleiss
Steven Finkbeiner
P2860
P304
16982-16987
P356
10.1073/PNAS.1004498107
P407
P577
2010-09-10T00:00:00Z